Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2006 1
2007 1
2012 1
2013 3
2014 2
2015 4
2016 3
2017 3
2018 11
2019 7
2020 8
2021 19
2022 14
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
Barsch M, Salié H, Schlaak AE, Zhang Z, Hess M, Mayer LS, Tauber C, Otto-Mora P, Ohtani T, Nilsson T, Wischer L, Winkler F, Manne S, Rech A, Schmitt-Graeff A, Bronsert P, Hofmann M, Neumann-Haefelin C, Boettler T, Fichtner-Feigl S, van Boemmel F, Berg T, Rimassa L, Di Tommaso L, Saeed A, D'Alessio A, Pinato DJ, Bettinger D, Binder H, John Wherry E, Schultheiss M, Thimme R, Bengsch B. Barsch M, et al. Among authors: schultheiss m. J Hepatol. 2022 Aug;77(2):397-409. doi: 10.1016/j.jhep.2022.02.032. Epub 2022 Apr 1. J Hepatol. 2022. PMID: 35367533
[Hepatocellular Carcinoma].
Schultheiß M, Bengsch B, Thimme R. Schultheiß M, et al. Dtsch Med Wochenschr. 2021 Oct;146(21):1411-1420. doi: 10.1055/a-1226-3047. Epub 2021 Oct 20. Dtsch Med Wochenschr. 2021. PMID: 34670284 Review. German.
Addendum zur S2k-Leitlinie Gastrointestinale Blutungen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).
Götz M, Biecker E, Dechêne A, Schilling D, Zipprich A, Trebicka J; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (federführend); Deutsche Morbus Crohn und Colitis ulcerosa Vereinigung (DCCV); Deutsche Röntgengesellschaft (DRG); Deutsche Gesellschaft für interventionelle Radiologie (DeGiR); Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) und Chirurgische Arbeitsgemeinschaft für Endoskopie und Sonografie (CAES) der DGAV; Deutsche Gesellschaft für Internistische Intensivmedizin (DGIIN); Deutsche Gesellschaft für Innere Medizin (DGIM); Deutsche Gesellschaft für Kardiologie (DGK); Akademie für Ethik in der Medizin (AEM); Gesellschaft für Thrombose und Hämostaseforschung (GTH); Collaborators. Götz M, et al. Z Gastroenterol. 2022 Jul;60(7):1139-1145. doi: 10.1055/a-1788-3501. Epub 2022 Jul 11. Z Gastroenterol. 2022. PMID: 35817045 Free article. German. No abstract available.
Prediction of postembolization syndrome after transarterial chemoembolization of hepatocellular carcinoma and its impact on prognosis.
Roehlen N, Stoehr F, Müller L, Luxenburger H, Gairing SJ, Reincke M, Schultheiss M, Berisha F, Weinmann A, Foerster F, Marquardt JU, Thimme R, Galle PR, Bettinger D, Kloeckner R. Roehlen N, et al. Among authors: schultheiss m. Hepatol Commun. 2023 Sep 27;7(10):e0252. doi: 10.1097/HC9.0000000000000252. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37756031 Free PMC article.
[Complications of liver cirrhosis].
Reincke M, Thimme R, Schultheiß M. Reincke M, et al. Among authors: schultheiss m. Dtsch Med Wochenschr. 2023 Oct;148(21):1371-1382. doi: 10.1055/a-2001-4236. Epub 2023 Oct 11. Dtsch Med Wochenschr. 2023. PMID: 37820648 German.
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Ripoll C, Platzer S, Franken P, Aschenbach R, Wienke A, Schuhmacher U, Teichgräber U, Stallmach A, Steighardt J, Zipprich A; Liver-HERO Study Group. Ripoll C, et al. Trials. 2023 Apr 5;24(1):258. doi: 10.1186/s13063-023-07261-9. Trials. 2023. PMID: 37020315 Free PMC article. Clinical Trial.
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M. Bettinger D, et al. Among authors: schultheiss m. J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26. J Hepatol. 2021. PMID: 33508376
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.
Sinner F, Pinter M, Scheiner B, Ettrich TJ, Sturm N, Gonzalez-Carmona MA, Waidmann O, Finkelmeier F, Himmelsbach V, De Toni EN, Ben Khaled N, Mohr R, Fründt TW, Kütting F, Bömmel FV, Lieb S, Krug S, Bettinger D, Schultheiß M, Jochheim LS, Best J, Müller C, Keitel V, Venerito M. Sinner F, et al. Among authors: schultheiss m. Cancers (Basel). 2022 Dec 2;14(23):5966. doi: 10.3390/cancers14235966. Cancers (Basel). 2022. PMID: 36497447 Free PMC article.
81 results